Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
<h4>Background</h4>Pancreatic cancer has an extremely poor prognosis and prolonged survival is achieved only by resection with macroscopic tumor clearance. There is a strong rationale for a neoadjuvant approach, since a relevant percentage of pancreatic cancer patients present with non-m...
Guardado en:
Autores principales: | Sonja Gillen, Tibor Schuster, Christian Meyer Zum Büschenfelde, Helmut Friess, Jörg Kleeff |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2fa11c4b18d40db9eff8f9eb3016d46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
por: Kamil D. Dalgatov, et al.
Publicado: (2021) -
Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
por: Guocan Yu, et al.
Publicado: (2021) -
Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-Analysis
por: Andrea Grego, et al.
Publicado: (2021) -
A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus
por: Yunpeng Zhao, et al.
Publicado: (2021) -
Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography
por: Xiawei Li, et al.
Publicado: (2022)